Literature DB >> 21734123

Reference intervals for common laboratory tests in Melanesian children.

Laurens Manning1, Moses Laman, Mary Anne Townsend, Stephen P Chubb, Peter M Siba, Ivo Mueller, Timothy M E Davis.   

Abstract

Pediatric reference intervals for biochemical tests are often derived from studies in Western countries and may not be applicable to the developing world. No such intervals exist for Melanesian populations. The aim of this study was to provide specific reference intervals for children from Papua New Guinea (PNG). We assayed plasma from 327 healthy Melanesian children living in Madang Province for common biochemical and hematological analytes. We used well-validated commercially available assay methodology. Compared with reference intervals from children from Western countries and/or African children, there were substantial differences in hemoglobin, soluble transferrin receptor, ferritin, calcium, phosphate, and C-reactive protein. Differences in the upper limits of reference intervals for bilirubin and alanine aminotransferase were also observed. Available reference intervals from Western and African countries may be inappropriate in PNG and other Melanesian countries. This has implications for clinical care and safety monitoring in pharmaceutical intervention trials and vaccine studies.

Entities:  

Mesh:

Year:  2011        PMID: 21734123      PMCID: PMC3122342          DOI: 10.4269/ajtmh.2011.11-0095

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  27 in total

Review 1.  Bacterial skin infections in a tropical environment.

Authors:  A Mahé
Journal:  Curr Opin Infect Dis       Date:  2001-04       Impact factor: 4.915

2.  Population-based hematologic and immunologic reference values for a healthy Ugandan population.

Authors:  Eric S Lugada; Jonathan Mermin; Frank Kaharuza; Elling Ulvestad; Willy Were; Nina Langeland; Birgitta Asjo; Sam Malamba; Robert Downing
Journal:  Clin Diagn Lab Immunol       Date:  2004-01

Review 3.  C-reactive protein: a critical update.

Authors:  Mark B Pepys; Gideon M Hirschfield
Journal:  J Clin Invest       Date:  2003-06       Impact factor: 14.808

4.  The importance of race and ethnic background in biomedical research and clinical practice.

Authors:  Esteban González Burchard; Elad Ziv; Natasha Coyle; Scarlett Lin Gomez; Hua Tang; Andrew J Karter; Joanna L Mountain; Eliseo J Pérez-Stable; Dean Sheppard; Neil Risch
Journal:  N Engl J Med       Date:  2003-03-20       Impact factor: 91.245

Review 5.  The evolution of the reference value concept.

Authors:  Ralph Gräsbeck
Journal:  Clin Chem Lab Med       Date:  2004       Impact factor: 3.694

6.  Haematological and biochemical indices in young African children: in search of reference intervals.

Authors:  Llorenç Quintó; John J Aponte; Jahit Sacarlal; Mateu Espasa; Pedro Aide; Inacio Mandomando; Caterina Guinovart; Eusebio Macete; Margarita M Navia; Ricardo Thompson; Clara Menéndez; Pedro L Alonso
Journal:  Trop Med Int Health       Date:  2006-11       Impact factor: 2.622

7.  alpha+-Thalassemia protects children against disease caused by other infections as well as malaria.

Authors:  S J Allen; A O'Donnell; N D Alexander; M P Alpers; T E Peto; J B Clegg; D J Weatherall
Journal:  Proc Natl Acad Sci U S A       Date:  1997-12-23       Impact factor: 11.205

8.  Vitamin D deficiency in early childhood: prevalent in the sunny South Pacific.

Authors:  Cameron C Grant; Clare R Wall; Sue Crengle; Robert Scragg
Journal:  Public Health Nutr       Date:  2009-02-23       Impact factor: 4.022

Review 9.  Selecting clinically relevant populations for reference intervals.

Authors:  Robert F Ritchie; Glenn Palomaki
Journal:  Clin Chem Lab Med       Date:  2004       Impact factor: 3.694

10.  Vitamin D insufficiency in Greenlanders on a westernized fare: ethnic differences in calcitropic hormones between Greenlanders and Danes.

Authors:  L Rejnmark; M E Jørgensen; M B Pedersen; J C Hansen; L Heickendorff; A L Lauridsen; G Mulvad; C Siggaard; H Skjoldborg; T B Sørensen; E B Pedersen; L Mosekilde
Journal:  Calcif Tissue Int       Date:  2003-12-23       Impact factor: 4.333

View more
  10 in total

1.  Prevalence of patients with acute febrile illnesses and positive dengue NS1 tests in a tertiary hospital in Papua New Guinea.

Authors:  Viola Asigau; Evelyn K Lavu; William J H McBride; Eric Biloh; Francis Naroi; Egi Koana; John K Ferguson; Moses Laman
Journal:  Am J Trop Med Hyg       Date:  2014-10-20       Impact factor: 2.345

2.  Contribution of Malaria to Inhospital Mortality in Papua New Guinean Children from a Malaria-Endemic Area: A Prospective Observational Study.

Authors:  Moses Laman; Susan Aipit; Cathy Bona; Jimmy Aipit; Timothy M E Davis; Laurens Manning
Journal:  Am J Trop Med Hyg       Date:  2019-04       Impact factor: 2.345

3.  Artemisinin-naphthoquine combination therapy for uncomplicated pediatric malaria: a tolerability, safety, and preliminary efficacy study.

Authors:  John Benjamin; Brioni Moore; Sook Ting Lee; Michèle Senn; Susan Griffin; Dulci Lautu; Sam Salman; Peter Siba; Ivo Mueller; Timothy M E Davis
Journal:  Antimicrob Agents Chemother       Date:  2012-02-13       Impact factor: 5.191

4.  Pharmacokinetic properties of single-dose primaquine in Papua New Guinean children: feasibility of abbreviated high-dose regimens for radical cure of vivax malaria.

Authors:  Brioni R Moore; Sam Salman; John Benjamin; Madhu Page-Sharp; Leanne J Robinson; Elizabeth Waita; Kevin T Batty; Peter Siba; Ivo Mueller; Timothy M E Davis; Inoni Betuela
Journal:  Antimicrob Agents Chemother       Date:  2013-11-04       Impact factor: 5.191

5.  Features and prognosis of severe malaria caused by Plasmodium falciparum, Plasmodium vivax and mixed Plasmodium species in Papua New Guinean children.

Authors:  Laurens Manning; Moses Laman; Irwin Law; Cathy Bona; Susan Aipit; David Teine; Jonathan Warrell; Anna Rosanas-Urgell; Enmoore Lin; Benson Kiniboro; John Vince; Ilomo Hwaiwhanje; Harin Karunajeewa; Pascal Michon; Peter Siba; Ivo Mueller; Timothy M E Davis
Journal:  PLoS One       Date:  2011-12-22       Impact factor: 3.240

6.  Ultrasonographic assessment of splenic volume at presentation and after anti-malarial therapy in children with malarial anaemia.

Authors:  Moses Laman; Susan Aipit; Cathy Bona; Peter M Siba; Leanne J Robinson; Laurens Manning; Timothy M E Davis
Journal:  Malar J       Date:  2015-05-28       Impact factor: 2.979

7.  Clinical features and outcome in children with severe Plasmodium falciparum malaria: a meta-analysis.

Authors:  Laurens Manning; Moses Laman; Wendy A Davis; Timothy M E Davis
Journal:  PLoS One       Date:  2014-02-06       Impact factor: 3.240

8.  Artemisinin-naphthoquine versus artemether-lumefantrine for uncomplicated malaria in Papua New Guinean children: an open-label randomized trial.

Authors:  Moses Laman; Brioni R Moore; John M Benjamin; Gumul Yadi; Cathy Bona; Jonathan Warrel; Johanna H Kattenberg; Tamarah Koleala; Laurens Manning; Bernadine Kasian; Leanne J Robinson; Naomi Sambale; Lina Lorry; Stephan Karl; Wendy A Davis; Anna Rosanas-Urgell; Ivo Mueller; Peter M Siba; Inoni Betuela; Timothy M E Davis
Journal:  PLoS Med       Date:  2014-12-30       Impact factor: 11.069

9.  Community based reference interval of selected clinical chemistry parameters among apparently healthy Adolescents in Mekelle City, Tigrai, Northern Ethiopia.

Authors:  Getachew Belay; Gebreyohanes Teklehaymanot; Gebreslassie Gebremariam; Kelali Kaleaye; Hagos Haileslasie; Gebremedhin Gebremichail; Brhane Tesfanchal; Getachew Kahsu; Brhane Berhe; Kebede Tesfay; Lemlem Legesse; Ataklti Gebretsadik; Mistire Wolde; Aster Tsegaye
Journal:  PLoS One       Date:  2020-04-07       Impact factor: 3.240

10.  A Toll-like receptor-1 variant and its characteristic cellular phenotype is associated with severe malaria in Papua New Guinean children.

Authors:  L Manning; J Cutts; D I Stanisic; M Laman; A Carmagnac; S Allen; A O'Donnell; H Karunajeewa; A Rosanas-Urgell; P Siba; T M E Davis; P Michon; L Schofield; K Rockett; D Kwiatkowski; I Mueller
Journal:  Genes Immun       Date:  2015-12-03       Impact factor: 2.676

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.